drug
risedronate sodium
Marketedupdated 3mo agoby Allergan Finance LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(0)
nothing on the calendar yet
Trials studying risedronate sodium
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 9, 2028
~1.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Jan 9, 2028formulationUS 76454591.4y
- Jan 9, 2028formulationUS 76454601.4y
- Jan 16, 2026formulationUS 8246989
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that